Charles S. Craik

1.2k total citations
16 papers, 1.0k citations indexed

About

Charles S. Craik is a scholar working on Molecular Biology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, Charles S. Craik has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Materials Chemistry. Recurrent topics in Charles S. Craik's work include HIV/AIDS drug development and treatment (4 papers), Enzyme Structure and Function (4 papers) and HIV Research and Treatment (3 papers). Charles S. Craik is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Enzyme Structure and Function (4 papers) and HIV Research and Treatment (3 papers). Charles S. Craik collaborates with scholars based in United States, Netherlands and Iceland. Charles S. Craik's co-authors include Robert J. Fletterick, S.A. Gillmor, Robert J. Fletterick, Sanford Goldstein, Peter Vanderslice, Elizabeth Tam, George H. Caughey, Jeffrey N. Higaki, R. M. Stroud and Jennifer L. Harris and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Charles S. Craik

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles S. Craik United States 15 574 245 179 141 121 16 1.0k
Olan Dolezal Australia 24 1.0k 1.8× 220 0.9× 234 1.3× 139 1.0× 99 0.8× 54 1.6k
Christian Boudier France 26 845 1.5× 238 1.0× 143 0.8× 141 1.0× 71 0.6× 58 1.7k
John R. Somoza United States 20 765 1.3× 80 0.3× 114 0.6× 211 1.5× 170 1.4× 35 1.2k
Irmgard Mayr Germany 9 1.3k 2.2× 174 0.7× 392 2.2× 143 1.0× 46 0.4× 10 2.3k
Veronika Harmat Hungary 22 631 1.1× 430 1.8× 169 0.9× 276 2.0× 81 0.7× 76 1.4k
Christopher Tsu United States 26 1.4k 2.5× 163 0.7× 584 3.3× 100 0.7× 154 1.3× 34 1.8k
R. Crowther United States 18 927 1.6× 491 2.0× 165 0.9× 171 1.2× 292 2.4× 23 1.8k
Micah Steffek United States 16 459 0.8× 363 1.5× 101 0.6× 88 0.6× 120 1.0× 20 991
R M Jack United States 19 370 0.6× 499 2.0× 91 0.5× 45 0.3× 146 1.2× 34 1.1k
David B. Langley Australia 22 987 1.7× 310 1.3× 126 0.7× 65 0.5× 52 0.4× 46 1.6k

Countries citing papers authored by Charles S. Craik

Since Specialization
Citations

This map shows the geographic impact of Charles S. Craik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Craik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Craik more than expected).

Fields of papers citing papers by Charles S. Craik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Craik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Craik. The network helps show where Charles S. Craik may publish in the future.

Co-authorship network of co-authors of Charles S. Craik

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Craik. A scholar is included among the top collaborators of Charles S. Craik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Craik. Charles S. Craik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Poot, Stefanie A.H. de, Daniel R. Hostetter, Petra Van Damme, et al.. (2011). Human and mouse granzyme M display divergent and species-specific substrate specificities. Biochemical Journal. 437(3). 431–442. 33 indexed citations
2.
Bhatt, Ami S., Tamotsu Takeuchi, Bauke Ylstra, et al.. (2003). Quantitation of Membrane Type Serine Protease 1 (MT-SP1) in Transformed and Normal Cells. Biological Chemistry. 384(2). 257–66. 26 indexed citations
3.
Craik, Charles S., et al.. (2000). The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity.. Nature Structural Biology. 7(9). 762–765. 88 indexed citations
4.
Gillmor, S.A., Charles S. Craik, & Robert J. Fletterick. (1997). Structural determinants of specificity in the cysteine protease cruzain. Protein Science. 6(8). 1603–1611. 156 indexed citations
5.
Swaan, Peter W., C. T. Redemann, Mary X. Tang, et al.. (1997). Use of the Intestinal Bile Acid Transporter for the Uptake of Cholic Acid Conjugates with HIV-1 Protease Inhibitory Activity. Pharmaceutical Research. 14(2). 176–180. 37 indexed citations
6.
Smyth, Mark J., Phillip K. Darcy, Jennifer L. Harris, et al.. (1997). P-4 and RNKP-7, new granzyme-like serine proteases expressed in activated rat lymphocytes. The Journal of Immunology. 158(10). 4574–4583. 9 indexed citations
7.
Voss, James J. De, Z. SUI, Dianne L. DeCamp, et al.. (1994). Haloperidol-Based Irreversible Inhibitors of the HIV-1 and HIV-2 Proteases. Journal of Medicinal Chemistry. 37(5). 665–673. 26 indexed citations
8.
Eakin, Ann E., et al.. (1994). Atlantic cod cDNA encoding a psychrophilic chymotrypsinogen. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1219(1). 211–214. 26 indexed citations
9.
Matthews, Brian W., Charles S. Craik, & Hans Neurath. (1994). Can small cyclic peptides have the activity and specificity of proteolytic enzymes?. Proceedings of the National Academy of Sciences. 91(10). 4103–4105. 36 indexed citations
10.
Rose, Robert B., et al.. (1993). Structure of the protease from simian immunodeficiency virus: Complex with an irreversible nonpeptide inhibitor. Biochemistry. 32(46). 12498–12507. 26 indexed citations
11.
McGrath, Mary E., et al.. (1992). Perturbing the polar environment of Asp102 in trypsin: consequences of replacing conserved Ser214. Biochemistry. 31(12). 3059–3064. 66 indexed citations
12.
DeCamp, Dianne L., Lilia M. Babé, Rafael Salto, et al.. (1992). Specific inhibition of HIV-1 protease by boronated porphyrins. Journal of Medicinal Chemistry. 35(18). 3426–3428. 45 indexed citations
13.
Higaki, Jeffrey N., et al.. (1991). Crystal structure of rat trypsin-S195C at −150 °C. Journal of Molecular Biology. 219(3). 511–523. 15 indexed citations
14.
Vanderslice, Peter, et al.. (1990). Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.. Proceedings of the National Academy of Sciences. 87(10). 3811–3815. 189 indexed citations
15.
Higaki, Jeffrey N., et al.. (1989). Introduction of a cysteine protease active site into trypsin. Biochemistry. 28(24). 9256–9263. 77 indexed citations
16.
Sprang, Stephen R., R.J. Fletterick, R. M. Stroud, et al.. (1987). The Three-Dimensional Structure of Asn 102 Mutant of Trypsin: Role of Asp 102 in Serine Protease Catalysis. Science. 237(4817). 905–909. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026